Identification of arsenite-and arsenic diglutathione-binding proteins in human hepatocarcinoma cells

Toxicology and Applied Pharmacology

Volumn 242, Issue 2, 2010, Pages 119-125

  Mizumura, Ayano ^a   Watanabe, Takayuki ^a   Kobayashi, Yayoi ^a,b   Hirano, Seishiro ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

Author keywords

Affinity; Electrophoresis; Glutathione; HepG2; Pentavalent arsenic; Trivalent arsenic

Indexed keywords

ARSENIC DERIVATIVE; ARSENIC DIGLUTATHIONE; ARSENIC TRIOXIDE; ARSENOUS ACID DERIVATIVE; BINDING PROTEIN; CALRETICULIN; CYSTEINE; GLUTATHIONE; LIVER PROTEIN; PEROXIREDOXIN 1; PROTEIN DISULFIDE ISOMERASE; PROTEIN DISULFIDE ISOMERASE RELATED PROTEIN 5; PROTEIN PRECURSOR; SEPHAROSE; SYNTHETIC PEPTIDE; THIOREDOXIN REDUCTASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL PROTECTION; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOLIC FRACTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER CYTOSOL; PEPTIDE SYNTHESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ARSENIC; ARSENITES; CELL LINE, TUMOR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLUTATHIONE; HUMANS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS;

EID: 71249151029     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.10.013     Document Type: Article

References (29)

1. Aposhian H.V., and Aposhian M.M. Arsenic toxicology: five questions. Chem. Res. Toxicol. 19 (2006) 1-15
2. Chang K.N., Lee T.C., Tam M.F., Chen Y.C., Lee L.W., Lee S.Y., Lin P.J., and Huang R.N. Identification of galectin I and thioredoxin peroxidase II as two arsenic-binding proteins in Chinese hamster ovary cells. Biochem. J. 371 (2003) 495-503
3. Csanaky L., and Gregus Z. Species variations in the biliary and urinary excretion of arsenate, arsenite and their metabolites. Comp. Biochem. Physiol. C-Toxicol. Pharmacol. 131 (2002) 355-365
4. Donoghue N., Yam P.T., Jiang X.M., and Hogg P.J. Presence of closely spaced protein thiols on the surface of mammalian cells. Protein Sci. 9 (2000) 2436-2445
5. Hayakawa T., Kobayashi Y., Cui X., and Hirano S. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch. Toxicol. 79 (2005) 183-191
6. He X., and Ma Q. Induction of metallothionein I by arsenic via metal-activated transcription factor 1: critical role of C-terminal cysteine residues in arsenic sensing. J. Biol. Chem. 284 (2009) 12609-12621
7. Hoffman R.D., and Lane M.D. Iodophenylarsine oxide and arsenical affinity chromatography: new probes for dithiol proteins. Application to tubulins and to components of the insulin receptor-glucose transporter signal transduction pathway. J. Biol. Chem. 267 (1992) 14005-14011
8. Inanami O., Johnson J.L., and Babior B.M. The leukocyte NADPH oxidase subunit p47PHOX: the role of the cysteine residues. Arch. Biochem. Biophys. 350 (1998) 36-40
9. IPCS. Arsenic (1981), World Health Organization
10. IPCS. Arsenic and arsenic compounds (2001), World Health Organization, Geneva
11. Ito K., Bernardi R., Morotti A., Matsuoka S., Saglio G., Ikeda Y., Rosenblatt J., Avigan D.E., Teruya-Feldstein J., and Pandolfi P.P. PML targeting eradicates quiescent leukaemia-initiating cells. Nature 453 (2008) 1072-1078
12. Kala S.V., Kala G., Prater C.I., Sartorelli A.C., and Lieberman M.W. Formation and urinary excretion of arsenic triglutathione and methylarsenic diglutathione. Chem. Res. Toxicol. 17 (2004) 243-249
13. Kitchin K.T., and Wallace K. Arsenite binding to synthetic peptides based on the Zn finger region and the estrogen binding region of the human estrogen receptor-alpha. Toxicol. Appl. Pharmacol. 206 (2005) 66-72
14. Kitchin K.T., and Wallace K. Arsenite binding to synthetic peptides: the effect of increasing length between two cysteines. J. Biochem. Mol. Toxicol. 20 (2006) 35-38
15. Kitchin K.T., and Wallace K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. J. Inorg. Biochem. 102 (2007) 532-539
16. Kobayashi Y., Cui X., and Hirano S. Stability of arsenic metabolites, arsenic triglutathione [As(GS)3] and methylarsenic diglutathione [CH3As(GS)2], in rat bile. Toxicology 211 (2005) 115-123
17. Lallemand-Breitenbach V., Jeanne M., Benhenda S., Nasr R., Lei M., Peres L., Zhou J., Zhu J., Raught B., and de The H. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat. Cell Biol. 10 (2008) 547-555
18. Li Y.M., and Broome J.D. Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells. Cancer Res. 59 (1999) 776-780
19. Lin C.H., Huang C.F., Chen W.Y., Chang Y.Y., Ding W.H., Lin M.S., Wu S.H., and Huang R.N. Characterization of the interaction of galectin-1 with sodium arsenite. Chem. Res. Toxicol. 19 (2006) 469-474
20. Naranmandura H., Suzuki N., and Suzuki K.T. Trivalent arsenicals are bound to proteins during reductive methylation. Chem. Res. Toxicol. 19 (2006) 1010-1018
21. Petrick J.S., Jagadish B., Mash E.A., and Aposhian H.V. Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 14 (2001) 651-656
22. Piatek K., Schwerdtle T., Hartwig A., and Bal W. Monomethylarsonous acid destroys a tetrathiolate zinc finger much more efficiently than inorganic arsenite: mechanistic considerations and consequences for DNA repair inhibition. Chem. Res. Toxicol. 21 (2008) 600-606
23. Salnikow K., and Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem. Res. Toxicol. 21 (2008) 28-44
24. Samikkannu T., Chen C.H., Yih L.H., Wang A.S.S., Lin S.Y., Chen T.C., and Jan K.Y. Reactive oxygen species are involved in arsenic trioxide inhibition of pyruvate dehydrogenase activity. Chem. Res. Toxicol. 16 (2003) 409-414
25. Spuches A.M., Kruszyna H.G., Rich A.M., and Wilcox D.E. Thermodynamics of the As(III)-thiol interaction: arsenite and monomethylarsenite complexes with glutathione, dihydrolipoic acid, and other thiol ligands. Inorg. Chem. 44 (2005) 2964-2972
26. Suzuki K.T., Tomita T., Ogra Y., and Ohmichi M. Glutathione-conjugated arsenics in the potential hepato-enteric circulation in rats. Chem. Res. Toxicol. 14 (2001) 1604-1611
27. Tatham M.H., Geoffroy M.C., Shen L., Plechanovova A., Hattersley N., Jaffray E.G., Palvimo J.J., and Hay R.T. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 10 (2008) 538-546
28. Yan H., Wang N., Weinfeld M., Cullen W.R., and Le X.C. Identification of arsenic-binding proteins in human cells by affinity chromatography and mass spectrometry. Anal. Chem. 81 (2009) 4144-4152
29. Zhang X., Yang F., Shim J.Y., Kirk K.L., Anderson D.E., and Chen X. Identification of arsenic-binding proteins in human breast cancer cells. Cancer Lett 255 (2007) 95-106